हमारा समूह 1000 से अधिक वैज्ञानिक सोसायटी के सहयोग से हर साल संयुक्त राज्य अमेरिका, यूरोप और एशिया में 3000+ वैश्विक सम्मेलन श्रृंखला कार्यक्रम आयोजित करता है और 700+ ओपन एक्सेस जर्नल प्रकाशित करता है जिसमें 50000 से अधिक प्रतिष्ठित व्यक्तित्व, प्रतिष्ठित वैज्ञानिक संपादकीय बोर्ड के सदस्यों के रूप में शामिल होते हैं।
ओपन एक्सेस जर्नल्स को अधिक पाठक और उद्धरण मिल रहे हैं
700 जर्नल और 15,000,000 पाठक प्रत्येक जर्नल को 25,000+ पाठक मिल रहे हैं
Rabindran, Devendran V and Velmurugan D
Antibiotic resistance is a serious problem in the management of childhood infections. Bacteria have developed various mechanisms of resistance. Indiscriminate and irrational use of antibiotics have led to the emergence of superbugs which have developed resistance to multiple antibiotics. Nowadays research are showing promising role of usage of older antibiotics for treatment of resistant infections. Multidrug resistant gram negative infections is a challenging situation where combination therapy and drugs with gram positive coverage like vancomycin are showing positive results. Ampicillin is losing sensitivity and protocols have been modified in using cephalosporins as the first line in some units. Carbapenam resistance and ESBL are emerging among hospitalised patients. Similarly emergence of community acquired MRSA possessing a new virulence toxin (Panton-Valentine leukocidin) is a serious threat among childhood infections. Unfortunately of late only minimal resources are directed to the development of newer antibiotics. Its time to consider the emerging antibiotic resistance particularly among children as a serious issue and start rational antibiotic practice and develop unit specific antibiotic policy to fight against antibiotic resistance.